CinCor Pharma Overview

  • Founded
  • 2018
Founded
  • Status
  • Public
  • Employees
  • 10
Employees
  • Stock Symbol
  • CINC
Stock Symbol
  • Share Price
  • $27.15
  • (As of Monday Closing)

CinCor Pharma General Information

Description

CinCor Pharma Inc is a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases.

Contact Information

Website
www.cincor.com
Ownership Status
Publicly Held
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 200 Clarendon Street
  • 6th Floor
  • Boston, MA 02116
  • United States
+1 (513) 000-0000

CinCor Pharma Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CinCor Pharma Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$27.15 $25.03 $13.01 - $30.66 $914M 36.5M 275K -$1.08

CinCor Pharma Financials Summary

In Thousands,
USD 		TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
Revenue 0 0 0
EBITDA (22,335) (5,137)
Net Income (26,835) (22,299) (5,035)
Total Assets 147,264 26,800 11,924
Total Debt 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

CinCor Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CinCor Pharma‘s full profile, request access.

Request a free trial

CinCor Pharma Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore CinCor Pharma‘s full profile, request access.

Request a free trial

CinCor Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
CinCor Pharma Inc is a clinical-stage biopharmaceutical company focused on developing its lead clinical candidate, CIN-1
Drug Discovery
Boston, MA
10 As of 2022
00000
0000 0000-00-00
00000000 00000

00000000

ate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proiden
0000 000000000
Vienna, Austria
00.000
00000000000 00.000

000000 0

xercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in repreh
0000 000000000
Watertown, MA
00 As of 0000
000.00
00.00 0000-00-00
000000&0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

CinCor Pharma Competitors (61)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Apeptico Venture Capital-Backed Vienna, Austria 00.000 00000000000 00.000
000000 00000000000 Formerly VC-backed Watertown, MA 00 000.00 000000&0 000.00
0000000 0000000000 Formerly VC-backed Boston, MA 0 00000 000000000 00000
0000000 000 Venture Capital-Backed San Diego, CA 00 000.00 00000000000 000.00
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
You’re viewing 5 of 61 competitors. Get the full list »

CinCor Pharma Executive Team (7)

Name Title Board Seat Contact Info
Marc de Garidel Chief Executive Officer & Board Member
Mary Theresa Coelho Chief Financial Officer, Finance & Executive Vice President
Terry Coelho Executive Vice President, Chief Financial Officer & Chief Busi­ness De­vel­op­ment Of­fi­cer
Jonathan Isaacsohn MD Chief Scientific Officer & Board Member
Mason Freeman MD Executive Vice President
You’re viewing 5 of 7 executive team members. Get the full list »

CinCor Pharma Board Members (10)

Name Representing Role Since
August Troendle MD Self Board Member 000 0000
David Allison Ph.D 5AM Ventures Board Member 000 0000
James Healy MD Sofinnova Investments Chairman 000 0000
Jason Pitts Ph.D General Atlantic Board Member 000 0000
John Thero CinCor Pharma Board Member 000 0000
You’re viewing 5 of 10 board members. Get the full list »

CinCor Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial